Jun
2
Jun 6

ASCO 2017 | June 2-6, 2017

Cynvenio's LiquidBiopsy Rare Cell Isolation platform will be showcased at the Thermo Fisher Scientific booth #23123.

Apr
1
Apr 5

AACR Annual Meeting 2017

  • Walter E. Washington Convention Center

Research Propelling Cancer Prevention and Cures

The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research. 

Sep
22
Sep 24

AGBT Precision Health Conference

  • AGBT Precision Health Conference

Cynvenio's LiquidBiopsy workflow will be showcased at the Thermo Fisher Scientific booth.

Jun
3
Jun 7

ASCO 2016

  • McCormick Place

Cynvenio's LiquidBiopsy technology and workflow will be showcased at the Thermo Fisher Scientific booth #2062.

Apr
16
Apr 20

AACR 2016

  • Ernest N. Morial Convention Center

Cynvenio's LiquidBiopsy technology and workflow will be showcased at the Thermo Fisher Scientific booth #1530.

Mar
6
Mar 11

Molecular Med Tri-Con 2016

  • Moscone North Convention Center

Cynvenio's LiquidBiopsy technology will be showcased at booth #217.

Jan
24
Jan 27

PMWC 2016

  • Computer History Museum

Liquid Biopsy in Immunotherapy and Beyond
Presentation by Dr. Paul Y. Song
Jan 26th at 12:00 PM

Nov
5
Nov 7

AMP 2015 Annual Meeting

  • Austin Convention Center

Join nearly 2,000 molecular diagnostic professionals gather for the AMP Annual Meeting. Cynvenio's LiquidBiopsy platform will be showcased at the Thermo Fisher Scientific booth (#1301).

Aug
18
Aug 20

The Next Generation Dx Summit

  • Capital Hill Hotel

Cynvenio's LiquidBiopsy platform will be showcased at Cynvenio's booth at the Next Generation Dx Summit. 

Jul
1
4:00 am04:00

Free Live Webinar: LiquidBiopsy for peripheral monitoring

Cynvenio's Dr. Paul Dempsey will discuss how the LiquidBiopsy™ Platform was used in a breast cancer research study to evaluate epithelial tumor cells and tumor cells in epithelial mesenchymal transition (EMT) from circulating tumor cells (CTCs), cell-free DNA (cfDNA) and solid tissue samples.